Implications and mechanism of action of gabapentin in neuropathic pain

Archives of Pharmacal Research

Volumn 36, Issue 3, 2013, Pages 237-251

  Kukkar, Ankesh ^a   Bali, Anjana ^a   Singh, Nirmal ^a   Jaggi, Amteshwar Singh ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Descending inhibition; Diabetic neuropathy; Dorsal root ganglion; Gabapentin; Neuropathic pain; Post herpetic neuralgia

Indexed keywords

AMITRIPTYLINE; BENFOTIAMINE; CAPSAICIN; CARBAMAZEPINE; CLONIDINE; CYANOCOBALAMIN; DESIPRAMINE; DONEPEZIL; DULOXETINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LIDOCAINE; NARCOTIC ANALGESIC AGENT; NORTRIPTYLINE; OPIATE; OXCARBAZEPINE; OXYCODONE; PARACETAMOL; PLACEBO; PREGABALIN; PROTEIN KINASE C; ROPIVACAINE; TOPIRAMATE; TRAMADOL; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE; VOLTAGE GATED CALCIUM CHANNEL;

AKATHISIA; ALLODYNIA; ANALGESIC ACTIVITY; ANEJACULATION; ANORGASMIA; ATAXIA; CANCER PAIN; CELL MEMBRANE; CHOLESTASIS; CIRCADIAN RHYTHM; COMBINATION CHEMOTHERAPY; CONFUSION; CYTOPLASM; DELUSIONAL PARASITOSIS; DIABETIC NEUROPATHY; DIZZINESS; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; FLAPPING TREMOR; HUMAN; HYPERALGESIA; IMPOTENCE; LIBIDO DISORDER; LIVER TOXICITY; LOW DRUG DOSE; MONOTHERAPY; NERVE CELL; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; NONHUMAN; PAIN ASSESSMENT; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; PRESYNAPTIC MEMBRANE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEXUAL DYSFUNCTION; SOMNOLENCE; SPINAL CORD DORSAL HORN; SPINAL GANGLION; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA;

AMINES; ANALGESICS; ANIMALS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURALGIA; PAIN MEASUREMENT; SPINAL CORD;

EID: 84879549914     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0057-y     Document Type: Review

References (141)

1. Alden, K.J., and J. Garcia. 2001. Differential effect of gabapentin on neuronal and muscle calcium currents. Journal of Pharmacology and Experimental Therapeutics 297: 727-735.
2. Amr, Y.M. 2010. Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: A prospective, randomized, double blind trial. Pain Physician 13: 245-249.
3. Arai, Y.C., T. Matsubara, K. Shimo, K. Suetomi, M. Nishihara, T. Ushida, K. Kobayashi, C. Suzuki, A. Kinoshita, M. Kondo, S. Matsubara, R. Hayashi, Y. Tohyama, K. Nishida, and M. Arakawa. 2010. Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine. Journal of Anesthesia 24: 407-410.
4. Argoff, C.E. 2011. Review of current guidelines on the care of post herpetic neuralgia. Postgraduate Medicine 123: 134-142.
5. Attal, N., G. Mazaltarine, B. Perrouin-Verbe, T. Albert, and SOFMER French Society for Physical Medicine and Rehabilitation. 2009. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous). Annals of Physical and Rehabilitation Medicine 52: 124-141.
6. Baba, H., K. Shimoji, and M. Yoshimura. 2000. Norepinephrine facilitates inhibitory transmission in substantia gelatinosa of adult rat spinal cord (part 1): Effects on axon terminals of GABAergic and glycinergic neurons. Anesthesiology 92: 473-484.
7. Back, S.K., S.Y. Won, S.K. Hong, and H.S. Na. 2004. Gabapentin relieves mechanical, warm and cold allodynia in a rat model of peripheral neuropathy. Neuroscience Letters 368: 341-344.
8. Backonja, M., A. Beydoun, K.R. Edwards, S.L. Schwartz, V. Fonseca, M. Hes, L. LaMoreaux, and E. Garofalo. 1998. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 280: 1831-1836.
9. Backonja, M.M., D.M. Canafax, and K.C. Cundy. 2011. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin. Pain Medicine 12: 1098-1108.
10. Backonja, M., and R.L. Glanzman. 2003. Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials. Clinical Therapeutics 25: 81-104.
11. Bang, S., S. Yoo, and S.W. Hwang. 2009. Gabapentin attenuates the activation of transient receptor potential A1 by cinnamaldehyde. Experimental Neurobiology 18: 1-7.
12. Bauer, C.S., M. Nieto-Rostro, W. Rahman, A. Tran-Van-Minh, L. Ferron, L. Douglas, I. Kadurin, Y. Sri Ranjan, L. Fernandez-Alacid, N.S. Millar, A.H. Dickenson, R. Lujan, and A.C. Dolphin. 2009. The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. Journal of Neuroscience 29: 4076-4088.
13. Bautista, D.M., S.E. Jordt, T. Nikai, P.R. Tsuruda, A.J. Read, J. Poblete, E.N. Yamoah, A.I. Basbaum, and D. Julius. 2006. TRPA1 mediates the inflammatory actions of environment tal irritants and proalgesic agents. Cell 124: 1269-1282.
14. Berger, A., E. Dukes, B. McCarberg, M. Liss, and G. Oster. 2003. Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia. Clinical Therapeutics 25: 2809-2821.
15. Beydoun, A. 1999. Postherpetic neuralgia: Role of gabapentin and other treatment modalities. Epilepsia 40(Suppl 6): S51-S56.
16. Bilgir, O., M. Calan, F. Bilgir, L. Kebapçilar, A. Yüksel, Y. Yildiz, and I. Sari. 2009. Gabapentin-induced rhabdomyolysis in a patient with diabetic neuropathy. Internal Medicine 48: 1085-1087.
17. Biyik, Z., Y. Solak, H. Atalay, A. Gaipov, F. Guney, and S. Turk. 2012. Gabapentin versus pregabalin in improving sleep quality and depression in hemodialysis patients with peripheral neuropathy: A randomized prospective crossover trial. International Urology and Nephrology, May 29. [Epub ahead of print].
18. Bodensteiner, J.B., H.H. Morris, and G.S. Golden. 1981. Asterixis associated with sodium valproate. Neurology 31: 195-196.
19. Bookwalter, T., and M. Gitlin. 2005. Gabapentin-induced neurologic toxicities. Pharmacotherapy 25: 1817-1819.
20. Boroujerdi, A., J. Zeng, K. Sharp, D. Kim, O. Steward, and Z.D. Luo. 2011. Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states. Pain 152: 649-655.
21. Boulton, A.J. 2003. Treatment of symptomatic diabetic neuropathy. Diabetes/Metabolism Research and Reviews 19(Suppl 1): S16-S21.
22. Butterworth, R.F. 1996. Neuroactive aminoacids in hepatic encephalopathy. Metabolic Brain Disease 11: 165-173.
23. Cahill, C.M., and T.J. Coderre. 2002. Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist. Pain 95: 277-285.
24. Calabrò, R.S. 2011. Gabapentin and sexual dysfunction: An overlooked and underreported problem? Epilepsy & Behavior 22: 818.
25. 2+ channels. Proceedings of the National Academy of Sciences of the United States of America 102: 11230-11235.
26. Chandra, K., N. Shafiq, P. Pandhi, S. Gupta, and S. Malhotra. 2006. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: A randomized, double-blind clinical trial - the GONIP Trial. International Journal of Clinical Pharmacology and Therapeutics 44: 358-363.
27. Chen, S.R., and H.L. Pan. 2005. Effect of systemic and intrathecal gabapentin on allodynia in a new rat model of postherpetic neuralgia. Brain Research 1042: 108-113.
28. Cheshire, W.P. 2007. Trigeminal neuralgia: For one nerve a multitude of treatments. Expert Review of Neurotherapeutics 7: 1565-1579.
29. Chong, M.S., and J. Hester. 2007. Diabetic painful neuropathy: Current and future treatment options. Drugs 67: 569-585.
30. Chou, R., S. Carson, and B.K. Chan. 2009. Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: Discrepancies between direct and indirect meta-analyses of randomized controlled trials. Journal of General Internal Medicine 24: 178-188.
31. Chu, L.C., M.L. Tsaur, C.S. Lin, Y.C. Hung, T.Y. Wang, C.C. Chen, and J.K. Cheng. 2011. Chronic intrathecal infusion of gabapentin prevents nerve ligation-induced pain in rats. British Journal of Anaesthesia 106: 699-705.
32. Coderre, T.J., N. Kumar, C.D. Lefebvre, and J.S. Yu. 2007. A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. Journal of Neurochemistry 100: 1289-1299.
33. Dallocchio, C., C. Buffa, P. Mazzarello, and S. Chiroli. 2000. Gabapentin vs. amitriptyline in painful diabetic neuropathy: An open-label pilot study. Journal of Pain and Symptom Management 20: 280-285.
34. Davies, A., J. Hendrich, A.T. Van Minh, J. Wratten, L. Douglas, and A.C. Dolphin. 2007. Functional biology of the alpha (2) delta subunits of voltage gated calcium channels. Trends in Pharmacological Sciences 28: 220-228.
35. Dworkin, R.H., A.B. O'Connor, M. Backonja, J.T. Farrar, N.B. Finnerup, T.S. Jensen, E.A. Kalso, J.D. Loeser, C. Miaskowski, T.J. Nurmikko, R.K. Portenoy, A.S. Rice, B.R. Stacey, R.D. Treede, D.C. Turk, and M.S. Wallace. 2007. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 132: 237-251.
36. Erdoǧan, G., D. Ceyhan, and S. Güleç. 2011. Possible heart failure associated with pregabalin use: Case report. Agri 23: 80-83.
37. Ermis, N., H. Gullu, M. Caliskan, A. Unsal, M. Kulaksizoglu, and H. Muderrisoglu. 2010. Gabapentin therapy improves heart rate variability in diabetic patients with peripheral neuropathy. Journal of Diabetes and Its Complications 24: 229-233.
38. Field, M.J., P.J. Cox, E. Stott, H. Melrose, J. Offord, T.Z. Su, S. Bramwell, L. Corradini, S. England, J. Winks, R.A. Kinloch, J. Hendrich, A.C. Dolphin, T. Webb, and D. Williams. 2006. Identification of the α2-δ-1 subunit of voltage dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proceedings of the National Academy of Sciences of the United States of America 103: 17537-17542.
39. Folkesson, A., P.H. Honoré, L.M. Andersen, P. Kristensen, and O.J. Bjerrum. 2010. Low dose of donepezil improves gabapentin analgesia in the rat spared nerve injury model of neuropathic pain: Single and multiple dosing studies. Journal of Neural Transmission 117: 1377-1385.
40. Furuta, S., T. Shimizu, M. Narita, K. Matsumoto, N. Kuzumaki, S. Horie, T. Suzuki, and M. Narita. 2009. Subdiaphragmatic vagotomy promotes nociceptive sensitivity of deep tissue in rats. Neuroscience 164: 1252-1262.
41. Garry, E.M., A. Delaney, H.A. Anderson, E.C. Sirinathsinghji, R.H. Clapp, W.J. Martin, P.R. Kinchington, D.L. Krah, C. Abbadie, and S.M. Fleetwood-Walker. 2005. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 118: 97-111.
42. Gassner, M., R. Ruscheweyh, and J. Sandkühler. 2009. Direct excitation of spinal GABAergic interneurons by noradrenaline. Pain 145: 204-210.
43. Geber, C., U. Baumgärtner, R. Schwab, H. Müller, P. Stoeter, M. Dieterich, C. Sommer, F. Birklein, and R.D. Treede. 2009. Revised definition of neuropathic pain and its grading system: An open case series illustrating its use in clinical practice. American Journal of Medicine 122(10 Suppl): S3-S12.
44. Gilron, I., J.M. Bailey, D. Tu, R.R. Holden, A.C. Jackson, and R.L. Houlden. 2009. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: A double-blind, randomised controlled crossover trial. Lancet 374: 1252-1261.
45. Gilron, I., J.M. Bailey, D. Tu, R.R. Holden, D.F. Weaver, and R.L. Houlden. 2005. Morphine, gabapentin, or their combination for neuropathic pain. New England Journal of Medicine 352: 1324-1334.
46. 2+ channel α2-δ subunit in current stimulation and subunit interaction. Neuron 16: 431-440.
47. Hanna, M., C. O'Brien, and M.C. Wilson. 2008. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. European Journal of Pain 12: 804-813.
48. Hansson, E., H. Muyderman, J. Leonova, L. Allansson, J. Sinclair, F. Blomstrand, T. Thorlin, M. Nilsson, and L. Rönnbäck. 2000. Astroglia and glutamate in physiology and pathology: Aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication. Neurochemistry International 37: 317-329.
49. Hara, K., and T. Sata. 2007. Inhibitory effect of gabapentin on N-methyl-d-aspartate receptors expressed in Xenopus oocytes. Acta Anaesthesiologica Scandinavica 51: 122-128.
50. Haslam, C., and T. Nurmikko. 2008. Pharmacological treatment of neuropathic pain in older persons. Clinical Interventions in Aging 3: 111-120.
51. Hasnie, F.S., J. Breuer, S. Parker, V. Wallace, J. Blackbeard, I. Lever, P.R. Kinchington, A.H. Dickenson, T. Pheby, and A.S. Rice. 2007. Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behaviour, and the influence of analgesic drugs. Neuroscience 144: 1495-1508.
52. Hayashida, K., and J.C. Eisenach. 2008. Multiplicative interactions to enhance gabapentin to treat neuropathic pain. European Journal of Pharmacology 598: 21-26.
53. Hayashida, K., and J.C. Eisenach. 2011. A tropomyosine receptor kinase inhibitor blocks spinal neuroplasticity essential for the anti-hypersensitivity effects of gabapentin and clonidine in rats with peripheral nerve injury. Journal of Pain 12: 94-100.
54. Hayashida, K., H. Obata, K. Nakajima, and J.C. Eisenach. 2008. Gabapentin acts within the locus coeruleus to alleviate neuropathic pain. Anesthesiology 109: 1077-1084.
55. Hayashida, K., R. Parker, and J.C. Eisenach. 2007. Oral gabapentin activates spinal cholinergic circuits to reduce hypersensitivity after peripheral nerve injury and interacts synergistically with oral donepezil. Anesthesiology 106: 1213-1219.
56. 2+ channels. Journal of Neuroscience 22: 9331-9339.
57. Hemstreet, B., and M. Lapointe. 2001. Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy. Clinical Therapeutics 23: 520-531.
58. Hindmarsh, K.W., L. Tan, K. Sankaran, and V.A. Laxdal. 1989. Diurnal rhythms of cortisol, ACTH, and beta-endorphin levels in neonates and adults. Western Journal of Medicine 151: 153-156.
59. Hon, N.C., and Y.J. Fei. 2008. Prescription pattern of oral healthcare professionals in the use of anticonvulsants for trigeminal neuralgia. Annals of the Royal Australasian College of Dental Surgeons 19: 162-164.
60. Honarmand, A., M. Safavi, and M. Zare. 2011. Gabapentin: An update of its pharmacological properties and therapeutic use in epilepsy. Journal of Medical Sciences Research 16: 1062-1069.
61. Hoppa, M.B., B. Lana, W. Margas, A.C. Dolphin, and T.A. Ryan. 2012. α2δ expression sets presynaptic calcium channel abundance and release probability. Nature 486: 122-125.
62. Ifuku, M., M. Iseki, I. Hidaka, Y. Morita, S. Komatus, and E. Inada. 2011. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy. Pain Medicine 12: 1112-1116.
63. Jacob, P. C., R. P. Chand, and el-S. Omeima. 2000. Asterixis induced by gabapentin. Clin. Neuropharmacol, 23, 53.
64. Jaggi, A.S., and N. Singh. 2011. Role of different brain areas in peripheral nerve injury-induced neuropathic pain. Brain Research 1381: 187-201.
65. Jarvis, S.E., and G.W. Zamponi. 2007. Trafficking and regulation of neuronal voltage gated calcium channels. Current Opinion in Cell Biology 19: 474-482.
66. Jean, W.H., C.C. Wu, M.S. Mok, and W.Z. Sun. 2005. Starting dose of gabapentin for patients with post-herpetic neuralgia - a dose-response study. Acta Anaesthesiologica Taiwanica 43: 73-77.
67. Jones, S.L. 1991. Descending noradrenergic influences on pain. Progress in Brain Research 88: 381-394.
68. Kaufman, K.R., and P.J. Struck. 2011. Gabapentin-induced sexual dysfunction. Epilepsy & Behavior 21: 324-326.
69. Keskinbora, K., A.F. Pekel, and I. Aydinli. 2007. Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: A randomized open trial. Journal of Pain and Symptom Management 34: 183-189.
70. Kim, Y.S., H.K. Chang, J.W. Lee, Y.H. Sung, S.E. Kim, M.S. Shin, J.W. Yi, J.H. Park, H. Kim, and C.J. Kim. 2009. Protective effect of gabapentin on N-methyl-d-aspartate-induced excitotoxicity in rat hippocampal CA1 neurons. Journal of Pharmacological Science 109: 144-147.
71. 2+ signaling in Bergmann glial cells in situ. FASEB Journal 11: 566-572.
72. Ko, S.H., H.S. Kwon, J.M. Yu, S.H. Baik, I.B. Park, J.H. Lee, K.S. Ko, J.H. Noh, D.S. Kim, C.H. Kim, J.O. Mok, T.S. Park, H.S. Son, and B.Y. Cha. 2010. Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy. Diabetic Medicine 27: 1033-1040.
73. Kusunose, N., S. Koyanagi, K. Hamamura, N. Matsunaga, M. Yoshida, T. Uchida, M. Tsuda, K. Inoue, and S. Ohdo. 2010. Molecular basis for the dosing time-dependency of anti-allodynic effects of gabapentin in a mouse model of neuropathic pain. Molecular Pain 6: 83.
74. Kwan, K.Y., A.J. Allchorne, M.A. Vollrath, A.P. Christensen, D.S. Zhan, C.J. Woolf, and D.P. Corey. 2006. TRPA1 contributes cold, mechanical, and chemical nociception but is n essential for hair-cell transduction. Neuron 50: 277-289.
75. Lemos, L., R. Fontes, S. Flores, P. Oliveira, and A. Almeida. 2010. Effectiveness of the association between carbamazepine and peripheral analgesic block with ropivacaine for the treatment of trigeminal neuralgia. Journal of Pain Research 3: 201-212.
76. Li, C.Y., X.L. Zhang, E.A. Matthews, K.W. Li, A. Kurwa, A. Boroujerdi, J. Gross, M.S. Gold, A.H. Dickenson, G. Feng, and Z.D. Luo. 2006. Calcium channel α2-δ-1 subunit mediates spinal hyperexcitability in pain modulation. Pain 125: 20-34.
77. Liu, Y., N. Qin, T. Reitz, Y. Wang, and C.M. Flores. 2006. Inhibition of the rat brain sodium channel Nav1.2 after prolonged exposure to gabapentin. Epilepsy Research 70: 263-268.
78. Lloyd, A., C.S. Boomershine, E.H. Choy, A. Chandran, and G. Zlateva. 2012. The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective. Journal of Medicinal Economics 15: 481-492.
79. Lopez, P.R., T. Rachael, S. Leicht, and R.D. Smalligan. 2010. Gabapentin-induced delusions of parasitosis. Southern Medical Journal 103: 711-712.
80. Luo, Z.D., N.A. Calcutt, E.S. Higuera, C.R. Valder, Y.H. Song, C.I. Svensson, and R.R. Myers. 2002. Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. Journal of Pharmacology and Experimental Therapeutics 303: 1199-1205.
81. Ma, L.L., W. Liu, Y.G. Huang, N. Yang, and P.P. Zuo. 2011. Analgesic effect of gabapentin in a rat model for chronic constrictive injury. Chinese Medical Journal (English Edition) 124: 4304-4309.
82. Malarkey, E.B., and V. Parpura. 2008. Mechanisms of glutamate release from astrocytes. Neurochemistry International 52: 142-154.
83. 2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression. Neuropharmacology 42: 353-366.
84. Mich, P.M., and W.A. Horne. 2008. Alternative splicing of the Ca channel beta4 subunit confers specificity for gabapentin inhibition of Cav2.1 trafficking. Molecular Pharmacology 74: 904-912.
85. Mishra, S., S. Bhatnagar, G.N. Goyal, S.P. Rana, and S.P. Upadhya. 2012. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: A prospective randomized double-blind placebo-controlled study. American Journal of Hospice & Palliative Care 29: 177-182.
86. Mittal, M., M. Pasnoor, R.B. Mummaneni, S. Khan, A. McVey, D. Saperstein, L. Herbelin, L. Ridings, Y. Wang, M.M. Dimachkie, and R.J. Barohn. 2011. Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy. Journal of Neuroscience 121: 521-527.
87. Mixcoatl-Zecuatl, T., G.N. Quinonez-Bastidas, N.L. Caram-Salas, M. Ambriz-Tututi, C.I. Araiza-Saldana, H.I. Rocha-Gonzalez, R. Medina-Santillan, G. Reyes-Garcia, and V. Granados-Soto. 2008. Synergistic antiallodynic interaction between gabapentin or carbamazepine and either benfotiamine or cyanocobalamin in neuropathic rats. Methods and Findings in Experimental and Clinical Pharmacology 30: 431-441.
88. Miyano, K., H.B. Tang, Y. Nakamura, N. Morioka, A. Inoue, and Y. Nakata. 2009. Paclitaxel and vinorelbine, evoked the release of substance P from cultured rat dorsal root ganglion cells through different PKC isoform-sensitive ion channels. Neuropharmacology 57: 25-32.
89. Morello, C.M., S.G. Leckband, C.P. Stoner, D.F. Moorhouse, and G.A. Sahagian. 1999. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Archives of Internal Medicine 159: 1931-1937.
90. Morimoto, S., M. Ito, S. Oda, A. Sugiyama, M. Kuroda, and S. Adachi-Akahane. 2012. Spinal mechanism underlying the antiallodynic effect of gabapentin studied in the mouse spinal nerve ligation model. Journal of Pharmacological Science 118: 455-466.
91. O'Connor, A.B., K. Noyes, and R.G. Holloway. 2007. A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia. Journal of the American Geriatrics Society 55: 1176-1184.
92. Odrcich, M., J.M. Bailey, C.M. Cahill, and I. Gilron. 2006. Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: Diurnal pain variation and effects of analgesic therapy. Pain 120: 207-212.
93. Pandey, C.K., N. Singh, and P.K. Singh. 2008. Gabapentin for refractory idiopathic trigeminal neuralgia. Journal of the Indian Medical Association 106: 124-125.
94. Paradowski, B., and M. Bilinska. 2003. Gabapentin in the treatment of neuropathic pain in patients with type 2 diabetes mellitus. Pol Merkur Lekarski 15: 61-64.
95. Park, S., E.S. Ahn, D.W. Han, J.H. Lee, K.T. Min, H. Kim, and Y.W. Hong. 2008. Pregabalin and gabapentin inhibit substance P-induced NF-kappaB activation in neuroblastoma and glioma cells. Journal of Cellular Biochemistry 105: 414-423.
96. Parsons, B., L. Tive, and S. Huang. 2004. Gabapentin: A pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia. American Journal of Geriatric Pharmacotherapy 2: 157-162.
97. Patarica-Huber, E., N. Boskov, and M. Pjevic. 2011. Multimodal approach to therapy-related neuropathic pain in breast cancer. Journal of BUON 16: 40-45.
98. Pérez, C., A. Navarro, M.T. Saldaña, X. Masramón, and J. Rejas. 2010. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study. Clinical Therapeutics 32: 1357-1370.
99. Perloff, M.D., D.E. Thaler, and J.A. Otis. 2011. Anorgasmia with gabapentin may be common in older patients. American Journal of Geriatric Pharmacotherapy 9: 199-203.
100. Petraglia, F., F. Facchinetti, D. Parrini, G. Micieli, S. De Luca, and A.R. Genazzani. 1983. Simultaneous circadian variations of plasma ACTH, beta-lipotropin, beta-endorphin and cortisol. Hormone Research 17: 147-152.
101. Polgár, E., J.H. Fowler, M.M. McGill, and A.J. Todd. 1999. The types of neuron which contain protein kinase C gamma in rat spinal cord. Brain Research 833: 71-80.
102. -1 subunit. Journal of Pharmacology and Experimental Therapeutics 338: 240-245.
103. Rice, A.S., and S. Maton. 2001. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 94: 215-224.
104. Richardson, C.E., D.W. Williams, and J.G. Kingham. 2002. Gabapentin induced cholestasis. BMJ 325: 635.
105. Rock, D.M., K.M. Kelly, and R.L. Macdonald. 1993. Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Research 16: 89-98.
106. 2+ release in rat cerebellar Type-1 astrocytes. Neurochemistry 100: 1188-1202.
107. Ross, J.R., K. Goller, J. Hardy, J. Riley, K. Broadley, R. A'hern, and J. Williams. 2005. Gabapentin is effective in the treatment of cancer-related neuropathic pain: A prospective, open-label study. Journal of Palliative Medicine 8: 1118-1126.
108. Rowbotham, M., N. Harden, B. Stacey, P. Bernstein, and L. Magnus-Miller. 1998. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 280: 1837-1842.
109. Ruessmann, H.J. 2009. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: A real-world study in outpatients. Journal of Diabetes and Its Complications 23: 174-177.
110. Said, G. 2007. Diabetic neuropathy - a review. Nature Clinical Practice Neurology 3: 331-340.
111. Saldaña, M.T., C. Pérez, A. Navarro, X. Masramón, and J. Rejas. 2012. Pain alleviation and patient-reported health outcomes following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain in routine medical practice. Clinical Drug Investigation 32: 401-412.
112. Sandercock, D., M. Cramer, J. Wu, Y.K. Chiang, V. Biton, and M. Heritier. 2009. Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy: Efficacy and tolerability in a double-blind, randomized, controlled clinical trial. Diabetes Care 32: e20.
113. See, S., E. Hendriks, and L. Hsiung. 2011. Akathisia induced by gabapentin withdrawal. Annals of Pharmacotherapy 45: e31.
114. Selph, S., S. Carson, R. Fu, S. Thakurta, A. Low, and M. McDonagh. 2011. Drug class review: neuropathic pain: Final update 1 report [Internet]. Portland (OR): Oregon Health & Science University.
115. Takahashi, H., and N. Shimoyama. 2010. A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain. International Journal of Clinical Oncology 15: 46-51.
116. Takasu, K., H. Ono, and M. Tanabe. 2008. Gabapentin produces PKA-dependent pre-synaptic inhibition of GABAergic synaptic transmission in LC neurons following partial nerve injury in mice. Journal of Neurochemistry 105: 933-942.
117. Takasusuki, T., and T.L. Yaksh. 2011. The effects of intrathecal and systemic gabapentin on spinal substance P release. Anesthesia and Analgesia 112: 971-976.
118. Tanabe, M., K. Takasu, N. Kasuya, S. Shimizu, M. Honda, and H. Ono. 2005. Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse. British Journal of Pharmacology 144: 703-714.
119. Taylor, C.P. 1997. Mechanisms of action of gabapentin. Rev Neurol (Paris) 153(suppl 1): 539-545.
120. Taylor, C.P. 2009. Mechanisms of analgesia by gabapentin and pregabalin-calcium channel alpha2-delta [Cavalpha2-delta] ligands. Pain 142: 13-16.
121. Tsavaris, N., P. Kopterides, C. Kosmas, A. Efthymiou, H. Skopelitis, A. Dimitrakopoulos, E. Pagouni, D. Pikazis, P.V. Zis, and C. Koufos. 2008. Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: A pilot study. Pain Medicine 9: 1209-1216.
122. Tuccori, M., G. Lombardo, F. Lapi, A. Vannacci, C. Blandizzi, and M. Del Tacca. 2007. Gabapentin-induced severe myopathy. Annals of Pharmacotherapy 41: 1301-1305.
123. Vadalouca, A., E. Raptis, E. Moka, P. Zis, P. Sykioti, and I. Siafaka. 2012. Pharmacological treatment of neuropathic cancer pain: A comprehensive review of the current literature. Pain Practice 12: 219-251.
124. 2+ channel β4 subunit creates a uniquely folded N-terminal protein binding domain with cell-specific expression in the cerebellar cortex. Journal of Neuroscience 26, 2635-2644 (2006).
125. Vranken, J.H. 2009. Mechanisms and treatment of neuropathic pain. Central Nervous System Agents in Medicinal Chemistry 9: 71-78.
126. Walczak, J.S., V. Pichette, F. Leblond, K. Desbiens, and P. Beaulieu. 2005. Behavioural, pharmacological and molecular characterization of the saphenous nerve partial ligation: A new model of neuropathic pain. Neuroscience 132: 1093-1102.
127. Wallace, V.C., J. Blackbeard, A.R. Segerdahl, F. Hasnie, T. Pheby, S.B. McMahon, and A.S. Rice. 2007. Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain 130: 2688-2702.
128. Whittaker, C.A., and R.O. Hynes. 2002. Distribution and evolution of von Willebrand/integrin A domains: Widely dispersed domains with roles in cell adhesion and elsewhere. Molecular Biology of the Cell 13: 3369-3387.
129. Wodarski, R., A.K. Clark, J. Grist, F. Marchand, and M. Malcangio. 2009. Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats. European Journal of Pain 13: 807-811.
130. Xiao, W., A. Boroujerdi, G.J. Bennett, and Z.D. Luo. 2007. Chemotherapy-evoked painful peripheral neuropathy: Analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 144: 714-720.
131. Verkhratsky, A., and F. Kirchhoff. 2007. Glutamate-mediated neuronal-glial transmission. Anat 210: 651-660.
132. Yaksh, T.L. 2006. Calcium channels as therapeutic targets in neuropathic pain. Journal of Pain 7(1 Suppl 1): S13-S30.
133. Yamama, Y., K. Nishikawa, T. Funao, T. Mori, and A. Asada. 2010. Intrathecal gabapentin and clonidine synergistically inhibit allodynia in spinal nerve-ligated rats. Life Sciences 87: 565-571.
134. Yang, R.H., W.T. Wang, J.Y. Chen, R.G. Xie, and S.J. Hu. 2009. Gabapentin selectively reduces persistent sodium current in injured type-A dorsal root ganglion neurons. Pain 143: 48-55.
135. Yang, R.H., J.L. Xing, J.H. Duan, and S.J. Hu. 2005. Effects of gabapentin on spontaneous discharges and subthreshold membrane potential oscillation of type A neurons in injured DRG. Pain 116: 187-193.
136. Yang, J.L., B. Xu, S.S. Li, W.S. Zhang, H. Xu, X.M. Deng, and Y.Q. Zhang. 2012. Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats. Molecular Brain 5: 18.
137. Yeh, C.Y., S.C. Chung, F.L. Tseng, Y.C. Tsai, and Y.C. Liu. 2011. Biphasic effects of chronic intrathecal gabapentin administration on the expression of protein kinase C gamma in the spinal cord of neuropathic pain rats. Acta Anaesthesiologica Taiwanica 49: 144-148.
138. Yi, H., M.A. Kim, S.K. Back, J.S. Eun, and H.S. Na. 2011. A novel rat forelimb model of neuropathic pain produced by partial injury of the median and ulnar nerves. European Journal of Pain 15: 459-466.
139. Yoshizumi, M., J.C. Eisenach, and K. Hayashida. 2012a. Riluzole and gabapentinoids activate glutamate transporters to facilitate glutamate-induced glutamate release from cultured astrocytes. European Journal of Pharmacology 677: 87-92.
140. Yoshizumi, M., R.A. Parker, J.C. Eisenach, and K. Hayashida. 2012b. Gabapentin inhibits γ-amino butyric acid release in the locus coeruleus but not in the spinal dorsal horn after peripheral nerve injury in rats. Anesthesiology 116: 1347-1353.
141. Zakrzewska, J.M., and R. McMillan. 2011. Trigeminal neuralgia: The diagnosis and management of this excruciating and poorly understood facial pain. Postgraduate Medical Journal 87: 410-416.